PHAT
Phathom Pharmaceuticals, Inc. · Healthcare · Market cap $605.1M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Sep 8, 2026
Breedlove Robert Charles
Phathom Pharmaceuticals, Inc. (PHAT) has 28 SEC Form 4 filings (41 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Sep 8, 2026.
Inside the rolling window, 1 insider at Phathom Pharmaceuticals, Inc. reported no open-market purchases and 1 open-market sale totaling $7K. The most recent open-market filing is a sale of 524 shares by Principal Accounting Officer Breedlove Robert Charles, dated Nov 3, 2025, worth $7K.
- Industry:Biotechnology
- CEO:Steven L. Basta
- Employees:371
- HQ:Florham Park, NJ, US
- IPO:2019-10-25
| Source | |||||||
|---|---|---|---|---|---|---|---|
Breedlove Robert CharlesFirst filing | Principal Accounting Officer | Sale | 524 | $7K | Nov 5 | -43.7% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does PHAT have?
Phathom Pharmaceuticals, Inc. (PHAT) has 28 SEC Form 4 filings (41 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Sep 8, 2026.
When was the most recent SEC Form 4 filing for PHAT?
The most recent Form 4 filing for PHAT on Tracefour is dated Sep 8, 2026.
What is the total insider buy and sell value at PHAT in the current window?
Inside the rolling window, insiders at PHAT bought $0 and sold $7K based on SEC Form 4 filings.
Can I get alerts for PHAT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Phathom Pharmaceuticals, Inc. (PHAT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Phathom Pharmaceuticals, Inc. is in the Healthcare sector.